|
|
|
Insider
Information: |
Schimmel Paul |
Relationship: |
Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
1,717,702 |
|
Indirect Shares
|
1,312,785 |
|
|
Direct
Value |
$98,588,229 |
|
|
Indirect Value
|
$46,439,304 |
|
|
Total
Shares |
3,030,487 |
|
|
Total
Value |
$145,027,533 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Alnylam Pharmaceuticals Inc |
ALNY |
Director |
2018-03-13 |
0 |
2018-03-13 |
306,996 |
Premium* |
|
Repligen Corp |
RGEN |
Director |
2007-06-14 |
665,106 |
2005-11-07 |
0 |
Premium* |
|
Avicena Group, Inc. |
AVCE |
Director |
2006-12-28 |
1,020,242 |
2005-11-23 |
0 |
Premium* |
|
aTyr Pharma Inc |
LIFE |
Director |
2023-05-10 |
8,890 |
2023-05-10 |
992,166 |
Premium* |
|
Forte Biosciences Inc |
FBRX |
Director |
2017-04-19 |
23,464 |
2017-04-19 |
13,623 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
84 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LIFE |
aTyr Pharma Inc |
Director |
|
2019-04-12 |
4 |
A |
$0.54 |
$1,000,000 |
I/I |
1,848,428 |
2,570,242 |
0 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2020-02-10 |
4 |
B |
$4.25 |
$1,079,500 |
I/I |
254,000 |
437,590 |
2.1 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2020-05-20 |
4 |
S |
$3.64 |
$30,739 |
I/I |
(8,447) |
429,143 |
0 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2021-05-18 |
4 |
B |
$3.98 |
$199,000 |
I/I |
50,000 |
113,023 |
2.1 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2021-09-20 |
4 |
GA |
$0.00 |
$0 |
I/I |
250,000 |
679,143 |
0 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2021-09-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
250,000 |
2,890 |
0 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2021-09-20 |
4 |
B |
$8.00 |
$2,000,000 |
D/D |
250,000 |
252,890 |
2.39 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2023-04-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,000 |
8,890 |
0 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2023-05-10 |
4 |
B |
$2.25 |
$450,000 |
I/I |
200,000 |
313,023 |
2.1 |
- |
|
84 Records found
|
|
Page 4 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|